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Abstract: Hepatitis E virus (HEV) is an emerging zoonotic pathogen that has received an increasing
amount of attention from virologists, clinicians, veterinarians, and epidemiologists over the past
decade. The host range and animal reservoirs of HEV are rapidly expanding and a plethora of emerging
HEV variants have been recently identified, some of which have the potential for interspecies infection.
In this review, the detection of genetically diverse HEV variants, classified into and presumably
associated with the species Orthohepevirus C, currently comprising HEV genotypes C1 and C2, by
either serological or molecular approach is summarized. The distribution, genomic variability, and
evolution of Orthohepevirus C are analyzed. Moreover, the potential risk of cross-species infection and
zoonotic transmission of Orthohepevirus C are discussed.
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1. Introduction
Hepatitis E Virus (HEV) is the causative viral pathogen of hepatitis E, originally considered
a self-limiting disease occurring only in developing countries with poor sanitary conditions [1].
Mortality rates in infected pregnant women can reach up to 25% during hepatitis E outbreaks in these
countries [2]. In the late 1990s, hepatitis E was recognized to be a zoonotic disease and swine was
found to be the natural host of HEV in the USA. Soon afterwards, a large number of autochthonous
cases were reported in different Europe countries associated with the consumption of undercooked
meat [3]. Hepatitis E poses a significant health risk for immunocompromised individuals, such as
solid organ transplant recipients and patients with human immunodeficiency virus infection, in whom
chronic infections can occur. Ribavirin is commonly administered as an off-label treatment for chronic
HEV infection, but significant side-effects often limit its use [4]. Furthermore, HEV may also cause
extrahepatic manifestations, including renal and neurological injuries, pancreatitis, cryoglobulinemia,
and hematological disorders [5]. In light of this, hepatitis E is being increasingly recognized as a serious
public health burden worldwide.
HEV was first isolated in 1983 and the viral genome was subsequently cloned and sequenced [6,7].
HEV is approximately 27–34 nm in diameter. Viral genomes are 6.4–7.2 kb long capped positive-sense
single-stranded RNA containing three open readings frames (ORF1, ORF2, and ORF3), 5′- and 3′-
untranslated regions, a 7-methylguanylate cap at the 5′ end and a polyadenine tract at the 3′-end. ORF1
encodes a non-structural polyprotein containing a methyltransferase, papain-like cysteine protease,
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macro domain, RNA helicase, and RNA-dependent RNA polymerase. ORF2 encodes the capsid
protein. ORF3 overlaps partially with ORF2 and encodes a multifunctional phosphoprotein associated
with viral egress [8]. Recent studies have reported that HEV particles are non-enveloped and infectious
in bile and feces, while quasi-enveloped and less infectious/non-infectious in sera [9].
HEV differs from all other human hepatitis viruses in that it is closely related to non-human
viruses [10]. HEV is the prototype of the family Hepeviridae, which includes the genera Orthohepevirus
and Piscihepevirus. The genus Orthohepevirus is further divided into four species Orthohepevirus A
to D. Orthohepevirus A contains HEV variants isolated from human, pig, wild boar, deer, mongoose,
rabbit, and camel; Orthohepevirus B from chicken; Orthohepevirus C from rat, greater bandicoot, Asian
musk shrew, ferret, and mink; and Orthohepevirus D from bat. The genus Piscihepevirus occurs in
cutthroat trout and possibly other fish species [11]. Based on the host range of viruses and phylogeny
of viral genomic sequences, proposals are also made for the designation of HEV genotypes and
subgenotypes [12]. Nevertheless, numerous novel HEV strains remain unclassified due to the large
degree of divergence or the lack of complete genomic sequences.
The species Orthohepevirus C is separated into two genotypes: HEV-C1 and HEV-C2. HEV-C1
contains variants derived from hosts in the orders Rodentia and Soricomorpha, and HEV-C2 from the
order Carnivora [8,11]. By means of the application and development of new molecular techniques
such as metagenomic sequencing, a growing number of distinct HEV variants have been discovered in
a variety of animal species globally and the species Orthohepevirus C has been rapidly extended in the
last years [13]. Although the zoonotic potential of Orthohepevirus C is still under debate, two recent
clinical cases describing persistent hepatitis in a liver transplant patient in Hong Kong and severe acute
hepatitis in an immunocompetent patient in Canada, respectively, have been attributed to infection
with rat HEV [14,15]. Furthermore, seven additional rat HEV infections have been confirmed lately in
Hong Kong [16]. In this review, we aim to compile and discuss the recent discoveries of HEV variants
within the species Orthohepevirus C and their potential risk of cross-species infection and zoonotic
transmission to humans.
2. Detection and Distribution of Orthohepevirus C
The first study concerning the prevalence of anti-HEV antibodies in wild rats was conducted in
the USA in 1999 [17]. In 2000, another study from the USA reported on the HEV seroprevalence among
13 rodent species, providing evidence for widespread infection of Orthohepevirus C in rodents and
suggesting these animals might be the natural reservoirs for this species of HEV [18]. Subsequently,
Orthohepevirus C RNA was detected in feces of Norway rats in Germany in 2010 using a nested
broad-spectrum reverse transcription polymerase chain reaction (RT-PCR) and the complete genomes
were sequenced and found to be highly divergent from human HEV strains [19,20]. Thus far, anti-HEV
or anti-rat HEV antibodies have been detected in 23 animal species, including 12 and 10 species within
the families Muridae and Cricetidae of the order Rodentia, respectively, and one species within the family
Soricidae of the order Soricomorpha, from eight countries (the USA, Japan, Germany, China, Vietnam,
Lithuania, Indonesia, and India). Additionally, Orthohepevirus C sequences have been detected in 22
countries (the USA, Germany, France, Denmark, China, Lithuania, Hungary, Austria, Switzerland,
Italy, Spain, Greece, Belgium, Czech Republic, England, Indonesia, Vietnam, Uganda, the Netherlands,
Japan, Brazil, and Kenya) and 25 animal species, containing eight species within the family Muridae
and 10 species within the family Cricetidae of the order Rodentia, one species within the family Ursidae
and two species within the family Mustelidae of the order Carnivore, two species within the family
Falconidae of the order Falconiformes, one species within the family Soricidae of the order Soricomorpha,
and one species within family Hominidae of the order Primates. Worldwide detection and distribution
of Orthohepevirus C is displayed in Figure 1. Although HEV serology and nucleic acid detection remains
negative in several of these animal species, this may be linked to limitations of current detection assays,
such as poor specificity and low sensitivity.
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Figure 1. Worldwide detection and distribution of Orthohepevirus C. Countries with both Orthohepevirus
C RNA and antibodies detection are in blue; countries with only antibodies detection are in green;
countries with only RNA detection are in orange. World map was created by using a free and open source
geographic information system Quantum Geographic Information System version 3.10 (http://qgis.
osgeo.org) and free vector and raster map data from Natural Earth (http://www.naturalearthdata.com).
2.1. Seroprevalence of Anti-HEV Antibodies
To date, 11 seroprevalence studies have been carried out on Rattus norvegicus (Brown rat/Norway
rat). In the USA, the seroprevalences of anti-HEV antibodies were 76.9% (83/108 samples tested positive)
between 1986 and 1997, 68.5% (135/197) between 1994 and 1998, and 73.5% (144/196) between 2005 and
2006, considerably higher than in other countries [17,18,21]. In Japan, the rates were 31.5% (114/362)
from 2000 through 2002, while another study with unreported sample collection dates resulted in
28.6% seroprevalence (16/56) [22,23]; in Germany, the seroprevalence was 24.5% (36/147) between 2007
and 2010 [24], comparable to China with 27.8% (64/230) between 2011 and 2012 [25]. In Vietnam, two
separate studies revealed similar seroprevalences of 20.3% (25/123) and 22.3% (21/94) in 2011 and an
additional study between 2012 and 2013 demonstrated a lower seroprevalence of 12.3% (48/389) [26–28].
In a recent study in Lithuania, the seroprevalence was 31.2% (34/109) between 2014 and 2017; however,
data were derived from both Norway rats (27) and Black rats (82) and individual species rates were
not indicated [29].
Six studies have been carried out in Rattus rattus (Black rat) with results varying considerably.
In the USA, one study reported a seroprevalence of 90.2% (102/113) between 1986 and 1997, yet
only 38.3% (31/81) between 1994 and 1998 in another [17,18]. In Indonesia, three studies have been
conducted with positive rates of 18.1% (21/116) between 2011 and 2012, 37.1% (137/369) in 2012, and
4.1% (10/242) between 2014 and 2016 [30–32]. In Japan, seroprevalence was 13.3% (12/90) from 2000
through 2002 [22].
Three studies in Vietnam found anti-HEV seroprevalences in Rattus tanezumi (Oriental house rat)
of 25.0% (4/16) and 33.3% (2/6) in 2011 and 19.6% (9/46) between 2012 and 2013 [26–28]. In a large-scale
investigation of sera of wild rats in China between 2011 and 2012, anti-HEV IgG rates in the species
Rattus rattoides losea (Losea rat), Rattus flavipectus (Yellow-breasted rat), Rattus rattus hainanus, and
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Bandicota indica (Greater bandicoot rat), were 21.5% (26/121), 19.9% (34/171), 11.8% (2/17), and 23.0%
(40/174), respectively [25]. In India, prevalence of anti-HEV Immunoglobulin G (IgG) was 15.8% (9/57)
in 1985 in Rattus rattus rufescens (Indian black rat), 3.6% (2/55) in 1990 in Rattus rattus andamanesis
(Sikkim rat), and 54.5% (12/22) in 1985 in Bandicota bengalensis (Lesser bandicoot rat) [33]. In the USA,
two species within the family Muridae, Rattus exulans (Polynesian rat) and Mus musculus (House rat),
had seroprevalences of 83.3% (15/18) between 1986 and 1997 and 14.3% (2/14) between 1994 and 1998,
respectively [17,18]. Lastly, a study conducted in Brazil in 2005 found two of four wild rats (species
unknown) were positive for anti-HEV IgG [34].
Antibodies against HEV were also found in multiple rodent species within the family
Cricetidae. Seroprevalence rates in Clethrionomys gapperi (Southern red-backed vole), Neotoma albigula
(White-throated woodrat), Neotoma mexicana (Mexican woodrat), Neotoma micropus (Southern plains
woodrat), Oryzomys palustris (Marsh rice rat), Peromyscus boylei (Brush mice), Peromyscus eremicus
(Cactus mouse), Peromyscus leucopus (White-footed mouse), Peromyscus maniculatus (North American
deermouse), and Sigmodon hispidus (Hispid cotton rat) were 66.7 (4/6), 59.1 (13/22), 57.1 (48/84), 12.5
(1/8), 24.4 (10/41), 8.3 (2/24), 42.9 (3/7), 10.0 (5/50), 11.0 (11/91), and 32.7 (37/113), respectively. Rodent
sera were collected during 1994–1998 throughout the USA and assessed by two in-house established
serological tests including antigens based on a mosaic protein composed of recombinant HEV ORF2
and ORF3 and a 55-kDa HEV ORF2 protein [18].
Additionally, seroprevalence in Suncus murinus (House shrew) within the family Soricidae of the
order Soricomorpha was 10.4% (27/260) for anti-HEV IgG and 4.6% (12/260) for Immunoglobulin M
(IgM), respectively, with samples collected between 2011 and 2012 in China [35]. The studies in terms
of seroprevalence of anti-HEV antibodies are summarized in Table 1.
Differing seroprevalence of anti-HEV antibodies may be due to different serological tests, which
have been carried out using commercial anti-HEV enzyme-linked immunosorbent assay (ELISA) kits or
conducted with in-house established assays based on diverse antigens (truncated or complete human
and rat HEV ORF2 protein) in numerous labs independently. Furthermore, although there is only
a single serotype of HEV, the cross-reaction of other known or unknown viral pathogens cannot be
excluded and may impact the results. Finally, no HEV seroprevalence studies have been performed on
species of the orders Carnivora and Falconiformes.
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Table 1. Seroprevalence of anti-HEV antibodies.
Order Family Species (Scientific Name) Common Name 1
No. Positive/No.
Tested (%) 3 Sampling Site (s) (Year) Assay Reference
Rodentia
Muridae
Rattus norvegicus Brown rat/Norway
rat
83/108 (76.9) The USA (1986–1997) In-house anti-HEV ELISA [17]
135/197 (68.5) The USA (1994–1998) In-house anti-HEV ELISAs [18]
144/196 (73.5) The USA (2005–2006) In-house anti-HEV ELISA [21]
114/362 (31.5) Japan (2000–2002) In-house anti-HEV ELISA [22]
16/56 (28.6) Japan (N.A.) Viragent HEV-Ab kit [23]
36/147 (24.5) Germany (2007–2010) In-house anti-rat HEV ELISA [24]
64/230 (27.8) China (2011–2012) In-house anti-rat HEV ELISA [25]
25/123 (20.3) Vietnam (2011) In-house anti-rat HEV ELISA [26]
21/94 (22.3) Vietnam (2011) In-house anti-rat HEV ELISA [27]
48/389 (12.3) Vietnam (2012–2013) In-house anti-rat HEV ELISA [28]
34/109 (31.2) 4 Lithuania (2014–2017) In-house anti-rat HEV ELISA [29]
Rattus rattus Black rat
102/113 (90.2) The USA (1986–1997) In-house anti-HEV ELISA [17]
31/81 (38.3) The USA (1994–1998) In-house anti-HEV ELISAs [18]
21/116 (18.1) Indonesia (2011–2012) In-house anti-HEV ELISA [30]
137/369 (37.1) Indonesia (2012) In-house anti-rat HEV ELISA [31]
10/242 (4.1) Indonesia (2014–2016) In-house anti-rat HEV ELISA [32]
12/90 (13.3) Japan (2000–2002) In-house anti-HEV ELISA [22]
Rattus tanezumi Oriental house rat
4/16 (25.0) Vietnam (2011) In-house anti-rat HEV ELISA [26]
2/6 (33.3) Vietnam (2011) In-house anti-rat HEV ELISA [27]
9/46 (19.6) Vietnam (2012–2013) In-house anti-rat HEV ELISA [28]
Rattus rattoides losea Losea rat 26/121 (21.5) China (2011–2012) In-house anti-rat HEV ELISA [25]
Rattus flavipectus Yellow-breastedrat 34/171 (19.9) China (2011–2012) In-house anti-rat HEV ELISA [25]
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Table 1. Cont.
Order Family Species (Scientific Name) Common Name 1
No. Positive/No.
Tested (%) 3 Sampling Site (s) (Year) Assay Reference
Rattus rattus hainanus N.A. 2 2/17 (11.8) China (2011–2012) In-house anti-rat HEV ELISA [25]
Bandicota indica Greater bandicootrat 40/174 (23.0) China (2011–2012) In-house anti-rat HEV ELISA [25]
Rattus rattus rufescens Indian black rat 9/57 (15.8) India (1985) In-house anti-HEV ELISA [33]
Rattus rattus andamanesis Sikkim rat 2/55 (3.6) India (1990) In-house anti-HEV ELISA [33]
Bandicota bengalensis Lesser bandicootrat 12/22 (54.5) India (1985) In-house anti-HEV ELISA [33]
Rattus exulans Polynesian rat 15/18 (83.3) The USA (1986–1997) In-house anti-HEV ELISA [17]
Mus musculus House rat 2/14 (14.3) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Cricetidae
Clethrionomys gapperi Southernred-backed vole 4/6 (66.7) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Neotoma albigula White-throatedwoodrat 13/22 (59.1) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Neotoma mexicana Mexican woodrat 48/84 (57.1) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Neotoma micropus Southern plainswoodrat 1/8 (12.5) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Oryzomys palustris Marsh rice rat 10/41 (24.4) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Peromyscus boylei Brush mice 2/24 (8.3) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Peromyscus eremicus Cactus mouse 3/7 (42.9) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Peromyscus leucopus White-footedmouse 5/50 (10.0) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Peromyscus maniculatus North Americandeermouse 11/91 (11.0) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Sigmodon hispidus Hispid cotton rat 37/113 (32.7) The USA (1994–1998) In-house anti-HEV ELISAs [18]
Soricomorpha Soricidae Suncus murinus House shrew 27/260 (10.4) China (2011–2012) In-house anti-rat HEV ELISA [35]
1 Taxonomy and common names refer to https://www.iucnredlist.org/. 2 N.A. stands for not available. 3 Seroprevalence indicates presence of anti-HEV IgG. 4 Positive rate derived from
both Rattus norvegicus and Rattus rattus, no individual species rates reported. HEV, hepatitis E virus; ELISA, enzyme-linked immunosorbent assay.
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2.2. Detection of Orthohepevirus C Genomes
Molecular biology methods, including RT-PCR amplification, Sanger sequencing and metagenomic
analysis with next-generation sequencing, have facilitated the detection of Orthohepevirus C (previously
designated rat HEV) RNA from liver, feces, and blood specimens of various animal species. Furthermore,
comprehensive sequence and phylogenetic analyses enable genotyping of viral strains. Consequently,
an increasing number of novel Orthohepevirus C variants have been discovered around the world
whose assignment remain to be determined.
Orthohepevirus C sequences were initially detected in Germany in the widespread rat species Rattus
norvegicus (Brown rat/Norway rat) [19,20]. To date, the vast majority of Orthohepevirus C genomes have
been identified in Norway rats, from countries including the USA, China, Germany, France, Denmark,
Lithuania, England, Hungary, Austria, Switzerland, Italy, Spain, Greece, Belgium, the Czech Republic,
and Vietnam, with all viral strains belonging to HEV-C1 [19,20,24,25,29,36–46]. Orthohepevirus C
genomes have been detected in numerous other members of the family Muridae: HEV-C1 from Rattus
rattus (Black Rat) has been detected in Indonesia, China, Kenya, and 12 other European countries
comprising Lithuania, Germany, Hungary, Denmark, Austria, Switzerland, France, Italy, Spain, Greece,
Belgium, and the Czech Republic [29,30,32,41,47,48]; Rattus tanezumi (Oriental house rat) in Vietnam
and China have also been reported to harbor the virus [26,36,44,49]; in China, HEV-C1 RNA has been
detected in Rattus losea (Losea rat), Rattus flavipectus (Yellow-breasted rat), and Bandicota indica (Greater
bandicoot rat) [25,43,44]; Apodemus chevrieri (Chevrier’s field mouse) and Apodemus agrarius (Striped
field mouse) were positive for Orthohepevirus C detection; however, these variants are phylogenetically
divergent from known HEV-C1 or HEV-C2, and thus, cannot yet be classified [36,50].
Consistent with serological studies, Orthohepevirus C RNA was found in several species within
other rodent families, including Cricetidae, containing Eothenomys melanogaster (Père David’s vole),
Eothenomys Inez (Inez’s red-backed vole), Myodes rufocanus (Grey red-backed vole), Microtus gregalis
(Narrow-headed vole), Cricetulus migratorius (Gray dwarf hamster), and Cricetulus barabensis (Striped
dwarf hamster) from China, Microtus arvalis (Common vole) from Hungary and Germany, Myodes
glareolus (Bank vole) from Germany, and Necromys Lasiurus (Hairy-tailed bolo mouse) and Calomys
tener (Delicate vesper) from Brazil [36,50–53]. The assignment of these newly identified HEV variants
remains unclear.
Additionally, Orthohepevirus C sequences have been detected in other animal species of mammals.
Within the family Soricidae of the order of Soricomorpha, the species Suncus murinus (House shrew/Asian
musk shrew) harbor HEV-C1 in China and Asian musk shrew have been implied as a reservoir for
HEV-C1 from wild rats, while the virus in the species Crocidura olivieri (Olivier’s shrew) from Kenya
cannot be assigned due to increased genetic divergence [35,44,48,50].
In the order Carnivora, HEV-C1 has been identified in a Syrian brown bear (species Ursus
arctos syriacus, family Ursidae) in a German zoo, most likely the result of a spillover infection from
free-roaming Norway rats [42]. In 2012, HEV-C2 was firstly reported in Western polecats (species
Mustela putorius) from the Netherlands [54]. Soon afterwards, HEV-C2 was detected in ferrets from the
USA, Japan, and China and in minks from Denmark and China [54–57]. Both species Mustela putorius
and Neovison vison belong to the carnivore family Mustelidae. Even though a short (362 nucleotide)
partial ORF1 sequence was identified in a red fox (species Vulpes vulpes, family Canidae), classification
into Orthohepevirus C requires comparisons based upon complete genome sequences, as recommended
by the International Committee on the Taxonomy of Viruses (ICTV) Hepeviridae Study group [58].
Recently, novel HEV variants have been reported from common kestrel (species Falco tinnunculus)
and red-footed falcon (species Falco vespertinus) within the family Falconidae of the order Falconiformes
in Hungary, notably the viral strain from kestrel showed higher sequence similarity to members of
Orthohepevirus C than to Orthohepevirus B and clustered together with aforementioned rodent HEV
variants from China and Brazil; therefore, the kestrel-derived HEV strain is included in this review [59].
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Finally, nine HEV-C1 strains have been reported in humans, eight being typical rat HEV sequences
from Hong Kong and the other divergent rat HEV sequence derived possibly from Uganda [14–16].
However, the precise source and transmission pattern of these nine HEV-C1 strains remain unclear.
The studies with regards to the detection of Orthohepevirus C genomes are listed in Table 2.
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Table 2. Detection of Orthohepevirus C genomes.
Order Family Species (ScientificName) Common Name





Rattus norvegicus Brown rat/Norwayrat
The USA (2003), Germany (2007–2010), Germany
(2009–2016), France (2011–2012), Denmark (2012),
China (2011–2012; 2013–2016; 2014–2017),
Lithuania (2014–2017), 11 European countries
(2005–2016) 2, England (2014–2016), Vietnam (2011;







Rattus rattus Black rat
Indonesia (2011–2012; 2014–2016), Lithuania
(2014–2017), Italy (2015), 11 European countries
(2005–2016), Kenya (2016); Museum collections
HEV-C1 Partial, Complete [29,30,32,41,47,48]
Rattus tanezumi Oriental house rat Vietnam (2011; 2012–2013), China (2013–2016;2014–2017) HEV-C1 Partial, Complete [26,28,36,44,49]
Rattus losea Losea rat China (2011–2012; 2014–2017) HEV-C1 Partial, Nearlycomplete [25,44]
Rattus flavipectus Yellow-breastedrat China (2011–2012) HEV-C1 Partial [25,43]
Bandicota indica Greater bandicootrat China (2011–2012) HEV-C1 Partial [25]
Apodemus chevrieri Chevrier’s fieldmouse China (2013–2015) N.A.
4 Partial, Complete [50]
Apodemus agrarius Striped fieldmouse China (2013–2016) N.A. Complete [36]
Cricetidae
Eothenomys
melanogaster Père David’s vole China (2013–2015) N.A. Partial, Complete [36,50]
Eothenomys inez Inez’s red-backedvole China (2013–2016) N.A. Complete [36]
Myodes rufocanus Grey red-backedvole China (2013–2016) N.A. Nearly complete [36]
Microtus gregalis Narrow-headedvole China (2013–2016) N.A. Complete [36]
Pathogens 2020, 9, 154 10 of 23
Table 2. Cont.
Order Family Species (ScientificName) Common Name










hamster China (2013–2016) N.A. Complete [36]
Microtus arvalis Common vole Hungary (2016), Germany and the Czech Republic(2009–2013) N.A. Partial, Complete [52,53]
Myodes glareolus Bank vole Germany (2009–2013) N.A. Partial [53]
Necromys lasiurus Hairy-tailed bolomouse Brazil (2008–2013) N.A. Nearly complete [51]






China (2011–2012; 2013–2016; 2014–2017) HEV-C1 Partial [35,43,44]
Crocidura olivieri Olivier’s shrew Kenya (2016) N.A. Partial [48]
Carnivora
Ursidae Ursus arctossyriacus Syrian brown bear Germany (2011–2016) HEV-C1 Partial [42]
Mustelidae
Mustela putorius Westernpolecat/ferret
The Netherlands (2010), the USA (2013), Japan
(2009–2013), China (2016), HEV-C2 Partial, Complete [54–56]
Neovison vison American mink Denmark (2008–2011), China (2016), HEV-C2 Partial [56,57]
Falconiformes Falconidae
Falco tinnunculus Common kestrel Hungary (2014) N.A. Partial, Complete [59]
Falco vespertinus Red-footed falcon Hungary (2014) N.A. Partial, [59]
Primates Hominidae Homo sapiens Human Hong Kong (2017–2019), Uganda (2017) HEV-C1 Complete [14–16]
1 Taxonomy and common names refer to https://www.iucnredlist.org/. 2 Sampling sites include Germany, Hungary, Denmark, Austria, Switzerland, France, Italy, Spain, Greece, Belgium,
and the Czech Republic. 3 Liver tissue samples from Rattus norvegicus and Rattus rattus rats from museum collections covering localities primarily in the USA plus additional samples from
China, Honduras, Madagascar, Mexico, Nicaragua, Peru, Russia, and Vietnam. 4 N.A. stands for not assigned. 5 Nearly complete indicates viral genome lacking 5′ end.
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3. Genomic Characterization of Orthohepevirus C
Despite the detection of Orthohepevirus C RNA in numerous species, the vast majority of deposited
sequences consist of partial HEV ORF1 or ORF2 genes. Complete genomic sequences of Orthohepevirus
C have been obtained from various mammal species, including Rattus norvegicus, Rattus rattus, Rattus
tanezumi, Rattus losea, Apodemus chevrieri, Apodemus agrarius, Eothenomys melanogaster, Eothenomys inez,
Myodes rufocanus, Microtus gregalis, Microtus arvalis, Necromys lasiurus, Cricetulus migratorius, Cricetulus
barabensis, Mustela putorius, Falco tinnunculus, and human (Table 1). For a better comparative analysis
and genomic characterization of Orthohepevirus C, the schematic description of genomic organization
of representative Orthohepevirus C variants from individual animal species is depicted in Figure 2.Pathogens 2020, 9, 154 12 of 25 
 
 
Figure 2. Schematic description of genomic organization of Orthohepevirus C variants. Virus 
designations including GenBank accession numbers and host information are indicated on the left. 
HEV open reading frames (ORFs) 1, 2, 3, and the putative ORF4 are represented in blue, green, 
brown, and yellow, respectively. The scale is in bases. 
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fragments (<500 bp). In order to determine the genetic variability of HEV variants within the species 
Orthohepevirus C, we have included 48 currently available complete or nearly complete genomic 
sequences of Orthohepevirus C from GenBank. The pairwise comparisons of complete genome and 
deduced ORFs of Orthohepevirus C is illustrated in Table 3. 
Unexpectedly, the genomic comparisons between HEV-C1 and other newly identified HEV 
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Figure 2. Schematic descript on f genomic rganizatio of Orthohepevirus C var ants. Virus designations
including Ge Bank accession numbers and host information are indicated on the left. HEV open
reading frames (ORFs) 1, 2, 3, and the putative ORF4 are repr sented in blu , gre , brown, and yellow,
respectively. The scale is in bases.
Overall, the genomic length of Orthohepevirus C sequences ranges from 6.8 to 7.2 kb, excluding
those without sequenced 5′ or 3′ ends. However, the distinct strain RtAa-HEV/JL2014 (GenBank
accession no. KY432900) from Apodemus agrarius, which consists of only 6286 nucleotides and has
a significant shorter ORF1 with 4334 nucleotides; moreover, RtAa-HEV/JL2014 lacks ORF3. Since
it has been recently reported that the ORF3 is essential for the release of membrane-associated rat
HEV particles, the absence of ORF3 in Apodemus agrarius needs further verification [60]. In addition to
RtAa-HEV/JL2014, the ORF1 of the strain RtCm-HEV/XJ2016 (GenBank accession no. KY432903) from
Cricetulus migratorius is only 4182 nucleotides in length. However, the short viral genome and ORF1, as
well as the absence of ORF3 may be associated with errors in assembling reads to contigs and mapping
assembled contigs to references in the metagenomic study [36].
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A unique ORF (tentatively named ORF4), located within the 5′ region of ORF1 has been proposed
in certain rat and ferret HEV strains [32,55]. As shown in Figure 2, all the HEV-C1 strains from the
species including Rattus norvegicus, Rattus rattus, Rattus tanezumi, and Rattus losea within the family
Muridae, two HEV-C1 analogues identified from humans, HEV-C2 strains from the family Mustelidae,
and the HEV variants from the species Necromys lasiurus and Microtus gregalis within the family
Cricetidae harbor ORF4. In contrast, this putative ORF is not found in other species. A recent study has
shown that ORF4 is not necessary for the active replication of rat HEV [60]. Therefore, the functional
role of the putative ORF4 remains poorly understood. Furthermore, due to the significant genetic
variability within Orthohepevirus C, the molecular evolution of ORF4 is as of yet unclear.
Typically, HEV ORF2 overlaps partially with ORF3 but not ORF1. However, three HEV variants
in the species Eothenomys melanogaster, identified from two separate studies, possess ORF2 genes
overlapping with ORF1. This is also the case for HEV strains in the species Eothenomys inez, Myodes
rufocanus, and Microtus gregalis within the family Cricetidae [8,36,50]. Additionally, the unique motif
at the 5‘-untranslated regions containing the 10 nucleotides GCAACCCCG is exclusively present in
HEV variants of the family Muridae [31]. Finally, Orthohepevirus C variants utilize distinct translational
frames, as described in our recent study [43].
Although many novel HEV variants within the Orthohepevirus C species have been discovered
in diverse wild rodents in China in a study based on metagenomic analysis, each species has only a
single viral complete genomic sequence [36]. The genomic features and genetic heterogeneity of these
HEV variants in individual animal species awaits the availability of more complete genome sequences.
4. Genetic Variability of Orthohepevirus C
As mentioned, the majority of described Orthohepevirus C sequences are partial genomic fragments
(<500 bp). In order to determine the genetic variability of HEV variants within the species Orthohepevirus
C, we have included 48 currently available complete or nearly complete genomic sequences of
Orthohepevirus C from GenBank. The pairwise comparisons of complete genome and deduced ORFs of
Orthohepevirus C is illustrated in Table 3.
Unexpectedly, the genomic comparisons between HEV-C1 and other newly identified HEV
strains derived from the rodent species Apodemus chevrieri, Apodemus agrarius, Eothenomys melanogaster,
Eothenomys inez, Myodes rufocanus, Microtus gregalis, Microtus arvalis, Necromys lasiurus, Cricetulus
migratorius, and Cricetulus barabensis exhibit comparable or even higher divergence than is present
between HEV-C1 and HEV-C2, even though HEV-C2 strains have only been found in the carnivore
species Mustela putorius. Nucleotide identities in Orthohepevirus C variants from individual rodent
species vary between 48.2–67.3%. Higher identities are observed between Eothenomys melanogaster
and Eothenomys Inez, ranging from 72.2 to 72.6%, and from 76.0 to 77.3% between Microtus gregalis and
Microtus arvalis. Similar results have been observed for the nucleotides and amino acids of the 3 coding
regions. Notably, for the comparison of ORF3, most of the HEV variants in their respective group are
highly divergent and exhibit low identities, especially at amino acid level (<20%). These data highlight
the fact that substantial genetic variability of HEV is present within the order Rodentia, raising a need
for increased efforts to characterize the variants circulating in the respective habitats. Only through
this will we be able to better assess the risk potential of these viruses to animal and human health.
Due to the high identity (> 75%) to HEV-C1 strains, two HEV variants detected in humans in
Hong Kong and Uganda can be considered as HEV-C1 [14,15]. Furthermore, the kestrel HEV strain
identified in Hungary shares relatively high similarity (> 83%) to the HEV strains from the species
Microtus arvalis from Hungary, Germany, and the Czech Republic, which is comparable to sequence
identities within common vole variants (between 81.5% and 91.9%). Therefore, it is assumed that the
detection of HEV variants in birds of prey (Common kestrel and Red-footed falcon) may be linked to
the consumption of wild rodents, in particular common voles [52,53,59].
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Table 3. Pairwise comparisons of complete genome and deduced ORFs of Orthohepevirus C variants.
Orthohepevirus C









(3) RdEiHEV (1) RdMrHEV (1)






HEV-C1 65.3–67.7 62.6–65.0 56.5–59.1 53.2–55.4 54.3–55.4 53.1–55.2 53.8–55.5 52.9–55.3 54.8–56.0 49.9–51.3 52.6–54.1
HEV-C2 63.5–65.9/69.5–74.0 58.5–58.6 62.1–62.8 54.6–55.6 54.7–54.9 53.3–53.7 54.8–55.0 53.1–54.4 54.9–55.1 53.4–53.6 51.1–51.5
RdAcHEV 61.0–63.9/64.4–67.861.0–61.6/67.8–68.5 66.2–66.4 54.3–55.0 54.5–54.7 53.6–53.8 54.5–54.9 53.0–54.1 54.5–54.6 52.7 50.4–51.0
RdAaHEV 54.8–56.5/57.1–61.15 .3–56.6/61.9–62.163.2–63.5/72.9–73.6 51.8–51.9 52.3 51.0 51.6 49.7–50.8 52.0 50.5 48.2
RdEmHEV 51.4–53.4/49.6–53.553.1–53.7/52.5–54.351.9–52.9/51.3–53.249.1–49.5/47.6–48.6 72.2–72.6 62.1–63.0 66.9–67.3 65.7–67.2 59.5–59.9 54.5–54.6 52.2–52.5
RdEiHEV 52.7–53.7/50.0–52.753.1–53.2/53.3–53.652.6–52.7/51.8–52.149.6/48.4 70.3–70.9/80.2–82.4 62.6 67.1 64.9–65.9 60.1 55.0 52.7
RdMrHEV 51.7–53.3/51.6–54.251.4–52.9/52.8–53.151.8–52.0/52.3–52.748.3/47.9 60.6–62.0/67.8–69.161.0/66.8 61.4 62.0–62.4 58.3 54.0 52.2
RdMgHEV 52.3–53.8/50.4–52.953.0–53.1/52.9–53.852.5–53.0/51.8–52.149.3/48.2 66.2–67.0/73.0–74.466.4/73.1 60.1/66.0 76.0–77.3 59.3 54.0 52.8
RdMaHEV 50.9–53.9/49.6–54.051.1–52.5/51.7–54.050.8–52.0/51.2–52.747.4–48.7/49.4–50.6 65.1–67.1/70.9–74.564.0–65.5/69.9–72.4 60.5–61.4/64.6–62.2 74.0–75.9/86.6–89.6 58.9–59.5 53.4–54.2 51.3–52.1
RdNlHEV 53.5–54.9/53.4–55.854.6/55.4–55.553.5–53.7/53.7–53.950.4/50.5 59.4–59.8/60.9–62.359.9/61.4 57.5/61.5 58.5/60.9 57.4–58.7/59.6–61.0 53.4 51.4
RdCmHEV 48.0–49.5/47.5–50.848.1–48.9/49.7–50.447.7/49.2–49.4 44.6/45.0 49.3–49.9/50.1–51.849.6/50.7 49.7/49.9 49.6/50.0 47.6–49.1/48.4–50.349.6/50.1 51.1
RdCbHEV 48.3–49.7/46.5–48.849.6–49.9/49.4–50.248.6–49.1/48.6–48.845.7/45.2 50.6–50.8/48.4–49.649.9/48.9 50.5/48.3 51.5/49.1 49.4–50.5/46.7–48.09.9/48.6 46.1/45.4
ORF1 (nt/aa)
ORF2 (nt/aa)
HEV-C1 66.5–72.8/76.4–81.663.2–69.7/70.7–74.959.6–66.1/68.2–73.3 57.0–61.9/60.7–63.05 .8–61.3/59.7–62.0 56.5–61.1/60.2–63.6 57.2–61.7/61.2–64.3 56.6–61.0/58.7–63.25 .6–60.6/63.0–65.75 .6–60.4/60.1–61.853.1–57.1/56.4–59.4
HEV-C2 59.0–63.6/37.0–45.4 64.5–65.4/70.4–71.062.9–63.4/69.8–70.2 58.5–60.4/58.9–59.658.1–58.6/58.0–59.3 57.7/60.9–61.8 59.6–60.9/60.6–61.5 57.7–59.2/57.7–59.958.9–59.4/61.3–62.557.9–58.3/59.3–59.856.7/56.8–58.1
RdAcHEV 59.2–62.6/39.6–50.054.6–56.4/32.1–35.7 70.1–70.4/85.6–85.8 60.4–61.5/62.3–62.959.6–60.3/61.6–61.8 59.1–59.6/61.2–61.8 60.3–60.8/63.2–63.5 58.1–60.0/60.1–61.659.4–59.5/61.8–62.359. /59.2 55.1–56.3/57.4–58.0
RdAaHEV N.A. 5 N.A. N.A. 58.0–58.4/60.4–60.758.7/60.4 57.4/59.0 57.4/60.2 55.1–56.4/57.9–58.77.6/60.4 57.1/57.8 53.8/55.6
RdEmHEV 40.1–44.8/20.0–27.841.3–46.7/21.0–26.940.9–44.3/22.2–28.2 N.A. 76.5–77.5/89.0–89.2 65.4–66.2/70.6–70.9 68.9–70.0/76.3–76.6 66.6–68.3/72.1–73.662.6–63.8/68.4–69.058.0–59.1/60.3–60.657.3–58.4/60.2–61.0
RdEiHEV 42.2–47.5/20.7–29.340.7–43.6/20.3–26.34 .6–42.9/23.7–25.4 N.A. 80.4–81.8/62.8–67.3 66.7/70.9 69.6/77.1 67.8–68.6/72.7–73.96 . /69.3 60.7/61.4 59.5/61.7
RdMrHEV 37.1–39.4/19.5–24.637.8–38.1/19.7–20.535.4–37.1/22.7 N.A. 52.0–53.4/30.8–32.556.2/39.0 66.1/69.7 65.1–66.2/67.4–68.63.2/68.5 59.0/60.6 57.8/60.9
RdMgHEV 38.6–41.6/19.5–24.439.1–41.0/19.7–22.836.9–38.2/20.8–21.6 N.A. 59.4–60.3/43.7–44.561.1/44.2 57.1/36.3 78.9–80.2/90.8–92.164. /67.1 59.9/62 57.3/61.4
RdMaHEV 36.3–40.2/10.2–18.936.5–38.9/10.9–17.837.8–39.5/10.1–15.5 N.A. 55.6–59.7/25.8–31.556.9–61.1/26.2–31.7 58.0–61.8/21.1–26.8 81.9–82.2/36.3–41.9 61.9–62.9/67.3–67.757.1–58.4/59.7–60.35 .3–57.0/58.7–59.6
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Table 3. Cont.
Orthohepevirus C









(3) RdEiHEV (1) RdMrHEV (1)





RdNlHEV 32.9–35.0/14.9–24.031.7–32.0/14.4–15.232.9–34.0/17.2–18.0 N.A. 40.8–41.9/24.6–27.944.6/27.6 37.9/24.2 41.4/30.3 43.5–45.9/20.3–23.4 59.8/64.1 57.5/61.2
RdCmHEV 38.2–43.1/17.8–27.137.6–38.1/17.7–22.640.3–41.7/23.3–25.0 N.A. 40.5–41.3/20.2–21.044.5/22.6 39.6/22.2 43.3/21.7 40.2–42.3/14.9–19.534.2/18.9 58.5/63.5
RdCbHEV 36.6–39.4/20.5–25.036.9–38.0/17.2–21.637.6–37.9/21.7–23.5 N.A. 33.9–35.0/16.0–20.235.8/21.8 33.2/15.6 32.3/19.7 31.2–32.2/15.9–21.433.0/15.9 39.9/18.9
ORF3 (nt/aa)
1 RdAcHEV, RdAaHEV, RdEmHEV, RdEiHEV, RdMrHEV, RdMgHEV, RdMaHEV, RdNlHEV, RdCmHEV, and RdCbHEV stand for HEV variants derived from the species Apodemus
chevrieri, Apodemus agrarius, Eothenomys melanogaster, Eothenomys inez, Myodes rufocanus, Microtus gregalis, Microtus arvalis, Necromys lasiurus, Cricetulus migratorius, and Cricetulus barabensis,
respectively. 2 Due to the sequence identity and phylogeny, two variants from humans (GenBank accession numbers MG813927 and MK050105) are included in the HEV-C1. 3 Nearly
complete genome. 4 Due to the sequence identity and phylogeny, a variant from Falco tinnunculus (GenBank accession number KU670940) is included in the RdMaHEV. 5 N.A. stands for
not available. Nucleotide (nt) and amino acid (aa) sequences were aligned using the MAFFT algorithm. Pairwise distances were computed in MEGA version 7. The GenBank Accession
numbers are as follows: MH729810, MH729811, MH729812, MG813927, AB847307, JN167538, JX120573, JN167537, KM516906, MK050105, GU345043, AB847308, GU345042, AB847305,
AB847306, AB847309, LC225388, LC225389, KY432898, and KY432906 for HEV-C1; AB890001, JN998606, JN998607, AB890374, LC057247, LC057248, LC177788, LC177789, LC177790,
LC177791, and LC177792 for HEV-C2; MG020022 and MG020023 for RdAcHEV; KY432900 for RdAaHEV; KY432905, MG020024 and MG020025 for RdEmHEV; KY432904 for RdEiHEV;
KY432901 for RdMrHEV; KY432902 for RdMgHEV; MK192405, MK192406, MK192407, MK192408, MK1924059, and KU670940 for RdMaHEV; MG021328 for RdNlHEV; KY432903 for
RdCmHEV; and KY432899 for RdCbHEV. Lightface type indicates nt identity, and boldface type indicates aa identity. Viral strains from rodent families Muridae and Cricetidae and carnivore
family Mustelidae are highlighted with grey, blue, and green background, respectively.
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5. Molecular Evolution of Orthohepevirus C
In order to investigate the dynamics of the molecular evolution of Orthohepevirus C, phylogenetic
analysis was conducted using representative complete genomic sequences within the genus
Orthohepevirus of the Hepeviridae family (Figure 3). The discrimination of genotypes within the
species Orthohepevirus A and C is in accordance with consensus proposals for the classification from
ICTV Hepeviridae study group [11]. Recently, we have reported novel HEV variants in Chevrier’s
field mouse (species Apodemus chevrieri, family Muridae) and Père David’s vole (species Eothenomys
melanogaster, family Cricetidae) in China and two viral genomes of each animal species were amplified
and characterized. Due to the significant divergence from HEV-C1 and HEV-C2, we have proposed
these variants be classified as putative HEV-C3 and putative HEV-C4, which has been included and
discussed in several recent research articles [13,50,53]. Afterwards, highly diverse HEV variants have
been discovered in other wild rodent species around the world [36,51,53]. Collectively, phylogenetic
tree shows that Orthohepevirus C variants form a separate branch within the genus Orthohepevirus.
Predictably, HEV variants detected in the rodent genus Rattus and the carnivore species Mustela
putorius cluster into two independent clades within the species Orthohepevirus C, which have already
been defined as HEV-C1 and HEV-C2, respectively. Even though newly identified HEV variants are
phylogenetically separate from HEV-C1 and HEV-C2, HEV variants from the rodent genus Apodemus
(including species Apodemus agrarius and Apodemus chevrieri), Eothenomys (including species Eothenomys
melanogaster and Eothenomys Inez), and Microtus (including the species Microtus gregalis and Microtus
gregalis) clustered into three distinct clusters, which are associated with rodent taxonomy and host
specificity. Taken together, it is hypothesized that co-evolutionary model, and not the host-switch
pattern, might be applied regarding the species Orthohepevirus C [10]. However, the HEV variants
derived from the rodent family Cricetidae, particularly RtCm-HEV/XJ2016 (GenBank accession no.
KY432903) from the species Cricetulus migratorius) and RtCb-HEV/HeB2014 (GenBank accession no.
KY432899) from Cricetulus barabensis, demonstrate a high degree of divergence within the Orthohepevirus
C clade. With no doubt that the evolutionary history of Orthohepevirus C will be better elucidated when
diversified HEV strains are discovered in insectivores and carnivores in the future.
The two HEV variants derived from a Chinese and Canadian patient, respectively, cluster within
the HEV-C1 branch, providing further evidence of a potential zoonotic origin [14,15]. Concordant
with pairwise comparisons of complete viral genomes and coding regions, the HEV strain (GenBank
accession no. KU670940) identified in a common kestrel (Falco tinnunculus) from Hungary clusters
together with the five reported HEV variants from European common voles (Microtus arvalis). Whether
Orthohepevirus C variants from common voles indeed can infect common kestrel remains to be
determined [52,53,59].
Thus far, all HEV variants detected in rodents have been isolated from the families Muridae and
Cricetidae. Considering that the order Rodentia comprises 33 families and 2277 species (>40% of all
mammal species), therefore forming the largest mammalian order, we believe that these HEV variants
are only the tip of the iceberg. Future studies will undoubtably reveal further novel variants within
Orthohepevirus C with new Orthohepevirus C genotypes being assigned in the coming years. Although
it is evident from our analyses that HEV variants within each genotype of Orthohepevirus C (including
HEV-C1, HEV-C2 and other unassigned groups) are highly divergent from one another, subtype
differentiation has not yet been proposed by ICTV Hepeviridae study group [11,31,53].
It is a well-known fact that evolution of HEV within the species Orthohepevirus A undergoes
different patterns between different genotypes (HEV-1 to HEV-8), which is associated with at least two
distinct epidemiological profiles of the species [61]. Increasingly genetically diversified viruses within
Orthohepevirus C have been identified; to what extent of viral evolutionary discrepancy of the species is
largely unclear.
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Mustelidae are highlighted with grey, blue, and green background, respectively. Complete genome 
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Figure 3. Maximum-likelihood phylogeny of Orthohepevirus C ariants within the genus Orthohepevirus.
Representatives of Orthohepevirus A, B, and D variants are reference strains according to the International
Committee on Taxonomy of Viruses (ICTV) consensus proposals [11]. Virus designations include
GenBank accession numbers and host information. Species and genotypes are indicated on the right.
Viral strains from rodent families Muridae and Cricetidae and carnivore family Mustelidae are highlighted
with grey, blue, and green background, respectively. Complete genome sequences were aligned using
the MAFFT algorithm. Phylogenetic reconstructions were performed using MEGA version 7 with 1000
bootstrap replicates. General Time Reversible (GTR) + Gamma Distributed (G) + Invariable Sites (I)
nucleotide substitution model was selected based on Find Best-Fit Substitution Model (ML) in MEGA
version 7. Bootstrap values (>75%) are indicated at specific nodes. Scale bars indicate the number of
nucleotide substitutions per site.
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6. Cross-Species Transmission of Orthohepevirus C
Human hepatitis E cases in industrialized countries are mainly caused by zoonotic transmission
of HEV-3 and HEV-4 within the species Orthohepevirus A; domestic swine, wild boar, and sika deer
have been confirmed to be the reservoirs. Typically, HEV zoonotic transmission occurs via three routes.
Firstly, population groups coming into direct contact with infected animals, such as veterinarians and
workers on pig farms or slaughterhouses, who were proven to have significantly higher anti-HEV IgG
seroprevalence rates than the general population and other veterinarians in some European countries;
secondly, foodborne transmission via consumption of undercooked infectious meat products (mostly
pork), such as sausages and liver, which is common in European countries; and thirdly, environmental
contamination by animal feces, since the use of pig manure in agriculture may lead to contamination
of water sources and agricultural products [3]. Furthermore, consumption of food products (milk and
meat) from camels and subsequent infection with a camelid HEV-7 strain was implicated in a case
of chronic hepatitis E after transplantation in a patient from the United Arab Emirates [62]. Using
reverse genetic systems, the potential of zoonotic infection of HEV-7 as well as HEV-5 from wild boar
have been confirmed by experimentally infecting primates in Japan [63,64]. Recently, one study has
demonstrated that HEV-8 from Bactrian camels in multiple regions in China was able to cause chronic
hepatitis in cynomolgus macaques (human surrogate), indicating a high risk of zoonosis [65]. Lastly,
rabbit HEV-3ra might also pose a potential threat to humans, based on described cross-species infection
of pigs and cynomolgus macaques [66,67].
Rodents are extraordinarily abundant and diversified in multiple continental habitats and live in
close proximity to humans, domestic animals, and wild animals. This interface has resulted in the
rodent origin of a plethora of zoonotic viruses, such as Lassa virus, Lymphocytic choriomeningitis virus,
Sin Nombre virus, Hantaan virus, and Seoul virus, all of which have caused severe diseases in humans
in the past decades [68]. Increasing amounts of evidence suggest that rodents may also play a role in
the spread and epidemiology of HEV. Numerous studies from different countries have reported that
rodent sera tested positive for anti-HEV antibodies were able to cross-react with human-derived HEV
antigens [17,18,21–23]. Initially, a 1996 study from Thailand reported experimental infection of three
Wistar laboratory rats with a human pathogenic HEV strain derived from patient feces acquired during
a hepatitis E outbreak in Nepal in 1992 [69]. Later, a Chinese study demonstrated the successfully
infection of Balb/c nude mice with swine HEV and active infection of Sprague-Dawley after intrahepatic
inoculation with infectious HEV-4 RNA [70]. A German study reported detectable HEV RNA and
anti-HEV antibodies in Wistar rats inoculated with a wild boar-derived HEV-3 strain [71]. In addition,
multiple rodent cell lines have been successfully infected with HEV-3 [72]. Finally, zoonotic HEV-3 was
reported in wild rats in the USA, England, and Japan, and a rabbit HEV-3ra sequence was detected in a
Norway rat from Belgium. However, viral RNA was mostly detected in intestines and feces and seldom
in the liver in these cases [23,41,46]. In contrast, the results from a series of studies demonstrated
that rats are susceptible to rat HEV but not HEV-1, HEV-2, or HEV-4 [37,73]. Therefore, the question
whether rodents are truly natural reservoirs of human HEV or act as only intermediate hosts is not yet
conclusively answered.
Although rodents have been confirmed to be the primary natural reservoirs of HEV variants
within the species Orthohepevirus C, the potential risk of these viruses concerning cross-species infection
and zoonotic transmission to humans remains a controversial topic [13]. In the past, Orthohepevirus
C variants were understudied and neglected due to their genetic divergence (identities <52%) to
the principle human pathogenic HEV strains (HEV-1 to HEV-4). It has been reported that pigs or
non-human primates (rhesus monkeys) inoculated with rat HEV showed no evidence of infection,
indicating that it is not a source of human infection [37,66]. In contrast, after screening with ELISAs
based on the capsid protein of Norway rat HEV, several sera from forestry works of eastern Germany
were shown to have strong reactivity [74]. In a recent study from Vietnam, IgG antibody titers against
HEV-C1 antigen in three of the 99 sera of hospitalized febrile patients were more than eight-fold higher
than those against HEV-1 antigen, while IgM antibodies against HEV-C1 antigen were detected in acute
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sera from two of the three patients using both ELISA and Western blotting and one patient developed
illness with mild liver dysfunction [75]. Furthermore, in Japan, a rat HEV reverse genetics system was
demonstrated to be replication competent in a human cell line, while another study reported that rat
HEV from Rattus rattus could propagate efficiently in human hepatoma cell lines including PLC/PRF/5,
HuH-7, and HepG2 [76]. Intriguingly, it was reported that a typical rat HEV caused persistent hepatitis
in a liver transplant patient in Hong Kong and that the virus was cleared after ribavirin treatment.
Additionally, a divergent rat HEV from Uganda induced severe acute hepatitis in an immunocompetent
patient from Canada. These two case reports provide first evidence of a possible zoonotic potential of
rat HEV [14,15]. Furthermore, based on comprehensive clinical and epidemiological analyses, seven
rat HEV infections have been further identified in Hong Kong, and these strains are extremely close to
an isolate from a rat captured near the residences of patients. Remarkably similar to Orthohepevirus A,
rat HEV have caused chronic viral infection in immunosuppressed individuals as well as extrahepatic
manifestations [16]. Jointly, it is highly presumable that rat HEV may be a cause of human hepatitis.
Nevertheless, there are still many open questions regarding zoonotic transmission of Orthohepevirus C.
What is the viral determinant for rat HEV cross-species infection? What is the effectivity of antiviral
therapy, especially regarding ribavirin, against rat HEV infection? Will other rat HEV analogues
(e.g., newly identified HEV strains from wild rodents, insectivores, and carnivores) be capable of
infecting humans?
Interspecies transmission of Orthohepevirus C variants has been characterized in several studies as
well. House shrews (Suncus murinus) have been reported as a reservoir of rat HEV worldwide; however,
a novel divergent HEV strain has been detected in a Olivier’s shrew (Crocidura olivieri) from Kenya and
formed a separate monophyletic branch from HEV-C1, indicating the relationship between the viral
species Orthohepevirus C and the animal order Soricomorpha should be more complex than previously
considered [35,43,44,48]. Although ferret HEV (HEV-C2) can cause both acute and persistent infection
in ferrets, researchers failed to infect monkeys and rats with ferret HEV [77].
7. Conclusions and Outlook
An increasing number of HEV variants are being detected in diverse animal species, including
mammals, avian, and fish, with some of these species having been confirmed as natural reservoirs for
HEV and sources of zoonotic infection. With the advancement of techniques such as high-throughput
sequencing in metagenomics studies, no doubt more novel HEV variants will be discovered in the
near future. The detection of numerous emerging HEV variants within the species Orthohepevirus
C has expanded the known host range of HEV dramatically. This raises critical concerns about
the potential risk of cross-species infection and zoonotic transmission to humans, as the biology,
ecology, natural history, and pathogenesis of these viruses are largely unknown. After three recent
reports identified totally nine human hepatitis E cases linked to rat HEV, the necessity to broaden our
knowledge concerning the molecular epidemiology of circulating Orthohepevirus C variants is clear,
and the potential risks of these viruses to public health should be reassessed. To elucidate the zoonotic
potential of Orthohepevirus C variants, the patterns of transmission, mechanisms of replication, and
functional roles of proteins merit further investigation.
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